Bioelectronics Corp (BIEL)

[ysprods]

NHS news will be out soon...


FREDERICK, Md., Feb. 18, 2016 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that B. Braun has initiated the application for a listing of RecoveryRx® on the National Health Service (NHS) drug tariff



39. NHS Prescription Services will acknowledge each application within 5 working days of receipt.

This is an example of the minimum time from receipt to approval and publishing in the Drug Tariff.


Activity Number of working days Example date

Application received N/A 01/05/09
Application acknowledged 5 06/05/09
Application assessed and taken
to a meeting 20 04/06/09
Acceptance letter written 5 11/06/09
Confirmation of detail of entry and
supplies available 35 1/08/09
Month listed in the Drug Tariff N/A September 2009

A number of factors may cause this timeline to be extended e.g. missing
documentation, complexity of information to be evaluated, applicants needing time to
provide further information. An application will not be released for assessment until all
the necessary information has been received. If, after 28 working days, the full
documentation has not been received by NHS Prescription Services, a reminder will be
sent asking for this to be sent within the next 28 days. Failure to send the missing
paperwork/samples will prompt NHS Prescription Services to ask for collection of any
paperwork/samples to be arranged within the next 7 days, after which they will be
destroyed. Any further applications for the product will then have to start anew.